Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Frontiers in Oncology|September 16, 2022
Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking statusMercedes Porosnicu, Anderson O'Brien Cox, Joshua D Waltonen, et al.Therapeutic Advances in Medical Oncology|January 22, 2024
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancerKimberly M Burcher, Chance H Bloomer, Elena Gavrila, et al.Plos One|October 25, 2014
Optimal brain MRI protocol for new neurological complaintWilliam A Mehan, R Gilberto González, Bradley R Buchbinder, et al.Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Horner Syndrome, Prachi Dubey, Nitesh Shekhrajka, et al.Cancers|April 14, 2025
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell CarcinomaMark J Chang, Daniel B Stamos, Cetin Urtis, et al.Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Vision Loss, Elliott R Friedman, Amy F Juliano, et al.JAMA Dermatology|July 8, 2026
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell CarcinomaBina Kassamali, Jonathan D Schoenfeld, Rosh Sethi, et al.Plos One|March 13, 2023
Incorporating algorithmic uncertainty into a clinical machine deep learning algorithm for urgent head CTsByung C Yoon, Stuart R Pomerantz, Nathaniel D Mercaldo, et al.The Lancet. Digital Health|April 22, 2023
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trialBenjamin H Kann, Jirapat Likitlersuang, Dennis Bontempi, et al.Journal of the American College of Radiology : JACR|November 19, 2021
ACR Appropriateness Criteria® Parathyroid Adenoma, David Zander, Paul M Bunch, et al.Pageof 9